MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 11..20 of 21 - per page Previous page Next page
Order by
The present invention utilizes the characteristic chemical property of hydrazide groups on one reactant to react with aldehyde groups or cyanate esters on the other reactant with an improved conjugate yield of at least sixty percent. More
A new non-formaldehyde method of producing improved botulinum toxoid. More
The conjugates of the invention are promising vaccines, especially for children and the elderly, who are most likely to suffer serious consequences from infection. More
Methods and compositions for making and using functionalized sugars More
Methods for SrgT synthesis and suggested modifications for production of SrgT analogs and related peptides More
A variety of new toxoids useful as botulinum vaccine antigens, for BAT or BIG production, or for development of tests to evaluate antigenicity of botulinum vaccines More
Aerosolized immunogenic compositions that may prove useful for vaccination against respiratory infections and may provide a platform for generating mucosal antibody responses against other pathogens. More
Use of Shewanella CPS conjugates as a component of an anthrax vaccine More
Monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague. More
Composition and method for prophylactic and therapeutic treatment of tularemia caused by Francisella tularensis More
Displaying 11..20 of 21 - per page Previous page Next page
Order by

Your selection

Therapeutic target
Infectious diseases del
Diseases del
Infection, bacterial(other) del

Browse By

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us